Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-11

Clinical Trial Update: A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial evaluated cervical priming with misoprostol before elective first-trimester abortion; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Kaiser Permanente | Conditions: Abortion, Therapeutic | Phase 2 | Status: COMPLETED